TANGEN BIOSCIENCES, INC.

BRANFORD, CT · Founded 2013 · CIK 0001661955 · Medtech · Private

TangenDx Molecular Diagnostic Platform for rapid pathogen identification and antibiotic susceptibility testing from blood samples using laser-drilled kapton filters for pathogen capture and concentrat

tangenbio.com →
Grants
$385K
2 awards
Sector median: 1
Raised
$20M
5 Form D · Jun 2023
39 months since last filing
Contracts
$11M
3 awards · Health and Human S
#64 of 4531 in medtech
Patents
24
6 granted · 18 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$2,030,403
Federal grantDepartment of Health and Human Services · Phase I · Rapid Detection of Multiple Drug resistant TB from Sputum$216,030
Private capital raisedForm D · SEC$8,000,000
Federal grantDepartment of Health and Human Services · Phase I · Rapid Detection of multiple sepsis pathogens$169,001
Federal contractDepartment of Health and Human Services · Igf::ct::igf$8,147,359
Private capital raisedForm D · SEC$6,689,846
Federal contractDepartment of Health and Human Services · Tangen SARS-COV-2 Assay$400,000
Private capital raisedForm D · SEC$11,239,731
Federal contractDepartment of Health and Human Services · EO14042 Tech Project # 6399: Scale Up Of Tangen Assay And Production$2,684,000
Private capital raisedForm D · SEC$464,767
Federal grant · SBIR/STTRFederal contract · USAspendingForm D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
61QUSPIN INC.$12M—
62ALTEC, INC$12M—
63ProteinSimple$11M—
64TANGEN BIOSCIENCES, INC.$11M$20M
65Countervail Corporation$11M—
66BLACKROCK MICROSYSTEMS, INC$11M$12M
67QUANTITATIVE BIOSCIENCES, INC.$11M—

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 10 related persons
  • Christopher BenoitDirector
  • Richard Birkmeyer, PhDDirector · Executive Officer
  • Brian ChiricoExecutive Officer
  • John DavidsonDirector · Executive Officer · Promoter
  • Vance KershnerDirector
  • Alan LevinDirector
  • Christopher McLeodDirector
  • John NobileDirector · Executive Officer · Promoter
  • Dan WagnerDirector
  • Daniel WagnerDirector

Patents

USPTO · 6 granted of 24

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.